Cite
Weston G, Rothe MJ, Kels BD, et al. The good, the bad, and the ugly of medication coverage: Is altering a diagnosis to ensure medication coverage ethical?. Int J Womens Dermatol. 2016;2(2):67-68doi: 10.1016/j.ijwd.2016.02.002.
Weston, G., Rothe, M. J., Kels, B. D., & Grant-Kels, J. M. (2016). The good, the bad, and the ugly of medication coverage: Is altering a diagnosis to ensure medication coverage ethical?. International journal of women's dermatology, 2(2), 67-68. https://doi.org/10.1016/j.ijwd.2016.02.002
Weston, Gillian, et al. "The good, the bad, and the ugly of medication coverage: Is altering a diagnosis to ensure medication coverage ethical?." International journal of women's dermatology vol. 2,2 (2016): 67-68. doi: https://doi.org/10.1016/j.ijwd.2016.02.002
Weston G, Rothe MJ, Kels BD, Grant-Kels JM. The good, the bad, and the ugly of medication coverage: Is altering a diagnosis to ensure medication coverage ethical?. Int J Womens Dermatol. 2016 Apr 14;2(2):67-68. doi: 10.1016/j.ijwd.2016.02.002. eCollection 2016 Jun. PMID: 28492011; PMCID: PMC5412101.
Copy
Download .nbib